Linda Heskamp received a Rubicon Grant from the Dutch Organisation for Scientific Research (NWO). The Rubicon program gives young, highly promising researchers the opportunity to gain international research experience.Project: Imaging muscle function in ALS patients.
In ALS patients, some muscles are frequently affected and others rarely. Linda wants to understand this by using a new imaging technique to investigate the muscle composition and function of several muscles in ALS patients to gather knowledge for the development of treatments.
Linda is traveling to the United Kingdom, Newcastle University, Campus for Ageing and Vitality, Newcastle Magnetic Resonance Centre, for 24 months.
International research experience is for many scientists an important step in their career. Thanks to the Rubicon grant young researchers can do their research at top institutes across the world for a maximum of 24 months. The size of the grant depends on the destination chosen and the length of stay.
Read also the story of researchers who previously received a Rubicon award here.
Related news items
Radboudumc Master Prize for Mark van Goor18 June 2019
Mark van Goor, theme Renal disorders, received the Radboudumc Master Prize for his MSc thesis entitled “High-resolution structure of the renal calcium channel TRPV5 revealed with cryo-EM”, which was based on his internship at the lab of Prof. Yifan Cheng, USA.read more
Exome sequencing in routine diagnostics: a generic test for 254 patients with primary immunodeficiencies18 June 2019
Exome sequencing may provide a genetic diagnosis in a significant number of patients in a single genetic test. Alexander Hoischen and Mihai Netea, theme Infectious diseases and global health, and colleagues, published their results in Genome Medicine.read more
Lowering cholesterol is not enough to reduce hyperactivity of the immune system14 June 2019
In Cell Metabolism, Siroon Bekkering, theme Vascular damage, and colleagues, provides a novel potential explanation for the residual cardiovascular risk, related to persistent activation of the immune system in patients with hypercholesterolemia who are treated with statins.read more